Alexion Pharmaceuticals closes a $111 million cash deal for Taligen assets
Alexion Pharmaceuticals has announced an all stock purchase of Taligen Therapeutics, a privately held company based in Cambridge, Massachusetts. The all cash upfront deal for… Read More »Alexion Pharmaceuticals closes a $111 million cash deal for Taligen assets